Literature DB >> 33050983

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.

Pyoeng Gyun Choe, Chang Kyung Kang, Hyeon Jeong Suh, Jongtak Jung, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Hong Bin Kim, Sang Won Park, Nam Joong Kim, Wan Beom Park, Myoung-Don Oh.   

Abstract

We investigated the kinetics of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in 7 asymptomatic persons and 11 patients with pneumonia. The geometric mean titer of neutralizing antibodies declined from 219.4 at 2 months to 143.7 at 5 months after infection, indicating a waning antibody response.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; ELISA; SARS-CoV-2; antibodies; coronavirus; coronavirus disease; neutralizing antibodies; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; waning immunity; zoonoses

Year:  2020        PMID： 33050983     DOI： 10.3201/eid2701.203515

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  42 in total

Review 1.  Practical guidance for clinical laboratories for SARS-CoV-2 serology testing.

Authors:  Carmen Charlton; Jamil Kanji; Vanessa Tran; Julianne Kus; Jonathan Gubbay; Carla Osiowy; Jason Robinson; Inna Sekirov; Michael Drebot; Todd Hatchette; Derek Stein; Nadia El-Gabalawy; Amanda Lang; Lei Jiao; Paul Levett; Heidi Wood; Christian Therrien; L Robbin Lindsay; Muhammad Morshed; Jessica Forbes; Antonia Dibernardo
Journal:  Can Commun Dis Rep       Date:  2021-05-07

2.  Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation.

Authors:  Lauren M Meyers; Andres H Gutiérrez; Christine M Boyle; Frances Terry; Bethany G McGonnigal; Andres Salazar; Michael F Princiotta; Wiliam D Martin; Anne S De Groot; Leonard Moise
Journal:  NPJ Vaccines       Date:  2021-05-13       Impact factor: 7.344

3.  Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination.

Authors:  Laura Matrajt; Julia Eaton; Tiffany Leung; Dobromir Dimitrov; Joshua T Schiffer; David A Swan; Holly Janes
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

4.  Determinants of IgG antibodies kinetics after severe and critical COVID-19.

Authors:  Julien De Greef; Anaïs Scohy; Francis Zech; Frank Aboubakar; Charles Pilette; Ludovic Gerard; Lucie Pothen; Halil Yildiz; Leïla Belkhir; Jean Cyr Yombi
Journal:  J Med Virol       Date:  2021-05-12       Impact factor: 20.693

5.  Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden.

Authors:  X Castro Dopico; S Muschiol; M Christian; L Hanke; D J Sheward; N F Grinberg; J Rorbach; G Bogdanovic; G M Mcinerney; T Allander; C Wallace; B Murrell; J Albert; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2021-05-18       Impact factor: 13.068

6.  Assessing vaccine durability in randomized trials following placebo crossover.

Authors:  Jonathan Fintzi; Dean Follmann
Journal:  Stat Med       Date:  2021-04-29       Impact factor: 2.497

7.  A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students.

Authors:  Christine C Lee; Hannah E Segaloff; Devlin Cole; Hannah G Rosenblum; Clint N Morgan; Tarah Somers; Rodel Desamu-Thorpe; Monique A Foster; Dustin Currie; Jeanne Ruff; David Payne; Thomas J Whyte; Glen R Abedi; John Paul Bigouette; Juliana Kahrs; Kimberly Langolf; Patrick Remington; Alana Sterkel; Patrick Kelly; Ryan P Westergaard; Allen C Bateman; Christopher H Hsu; Jacqueline E Tate; Hannah L Kirking
Journal:  BMC Infect Dis       Date:  2022-03-31       Impact factor: 3.090

8.  Antibody Responses One Year after Mild SARS-CoV-2 Infection.

Authors:  Pyoeng Gyun Choe; Kye Hyung Kim; Chang Kyung Kang; Hyeon Jeong Suh; EunKyo Kang; Sun Young Lee; Nam Joong Kim; Jongyoun Yi; Wan Beom Park; Myoung Don Oh
Journal:  J Korean Med Sci       Date:  2021-05-31       Impact factor: 2.153

9.  Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection.

Authors:  Irene Ramos; Carl Goforth; Alessandra Soares-Schanoski; Dawn L Weir; Emily C Samuels; Shreshta Phogat; Michelle Meyer; Kai Huang; Colette A Pietzsch; Yongchao Ge; Brian L Pike; James Regeimbal; Mark P Simons; Michael S Termini; Sindhu Vangeti; Nada Marjanovic; Stephen Lizewski; Rhonda Lizewski; Mary-Catherine George; Venugopalan D Nair; Gregory R Smith; Weiguang Mao; Maria Chikina; Christopher C Broder; Eric D Laing; Alexander Bukreyev; Stuart C Sealfon; Andrew G Letizia
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

10.  Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice.

Authors:  Ning Luan; Yunfei Wang; Han Cao; Kangyang Lin; Cunbao Liu
Journal:  J Med Virol       Date:  2022-02-08       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.